Goldman Sachs Group upgraded shares of VEON (NASDAQ:VEON) from a neutral rating to a buy rating in a research report sent to investors on Thursday, BenzingaRatingsTable reports. Goldman Sachs Group currently has $4.00 target price on the Wireless communications provider’s stock, up from their previous target price of $3.40.
VEON has been the topic of a number of other research reports. UBS Group downgraded shares of JinkoSolar from a buy rating to a neutral rating and increased their price target for the stock from $22.00 to $25.00 in a research note on Monday, June 17th. ValuEngine downgraded shares of Zynerba Pharmaceuticals from a buy rating to a hold rating in a research note on Tuesday, May 28th. Zacks Investment Research raised shares of SCHNEIDER ELEC /ADR from a hold rating to a buy rating and set a $20.00 price target on the stock in a research note on Friday, July 5th. Bank of America reaffirmed a buy rating and set a $43.00 price target (up previously from $36.00) on shares of The Medicines in a research note on Tuesday, July 9th. Finally, BidaskClub downgraded shares of Vertex Pharmaceuticals from a buy rating to a hold rating in a research note on Tuesday, July 9th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of $3.19.
Shares of NASDAQ VEON opened at $3.17 on Thursday. VEON has a 1 year low of $2.07 and a 1 year high of $3.28. The stock’s 50 day moving average price is $2.61. The firm has a market capitalization of $5.62 billion, a price-to-earnings ratio of -13.78 and a beta of 1.81.
VEON (NASDAQ:VEON) last posted its quarterly earnings results on Thursday, May 2nd. The Wireless communications provider reported $0.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.02. The company had revenue of $2.12 billion for the quarter. VEON had a net margin of 10.00% and a negative return on equity of 17.37%. Analysts predict that VEON will post 0.39 EPS for the current fiscal year.
A number of large investors have recently bought and sold shares of the business. Comerica Bank raised its stake in shares of VEON by 4.0% in the 4th quarter. Comerica Bank now owns 105,471 shares of the Wireless communications provider’s stock valued at $262,000 after acquiring an additional 4,101 shares during the period. SG Americas Securities LLC raised its stake in shares of VEON by 7.5% in the 1st quarter. SG Americas Securities LLC now owns 97,028 shares of the Wireless communications provider’s stock valued at $203,000 after acquiring an additional 6,780 shares during the period. Paloma Partners Management Co purchased a new position in shares of VEON in the 4th quarter valued at $30,000. Gabelli Funds LLC raised its stake in shares of VEON by 0.6% in the 1st quarter. Gabelli Funds LLC now owns 2,541,000 shares of the Wireless communications provider’s stock valued at $5,311,000 after acquiring an additional 15,000 shares during the period. Finally, FMR LLC raised its stake in shares of VEON by 8.6% in the 1st quarter. FMR LLC now owns 219,193 shares of the Wireless communications provider’s stock valued at $458,000 after acquiring an additional 17,387 shares during the period. 16.22% of the stock is currently owned by institutional investors.
VEON Ltd., through its subsidiaries, provides mobile and fixed-line telecommunications services. It offers voice and data telecommunication services through a range of mobile and fixed-line technologies. The company provides value added services, including short messages, multimedia messages, caller number identification, call waiting, data transmission, mobile internet, downloadable content, mobile finance services, machine-to-machine, and other services; national and international roaming services; wireless Internet access and mobile financial services; and mobile bundles and call completion services.
Featured Article: What is the Fibonacci sequence?
Receive News & Ratings for VEON Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VEON and related companies with MarketBeat.com's FREE daily email newsletter.